Donor Ankle Sensorimotor Recovery After ACL Reconstruction With a Peroneus Longus Tendon Autograft

August 10, 2026 updated by: Dudu Özdemir, Gazi University

Recovery of Donor Ankle Sensorimotor Function Following Anterior Cruciate Ligament Reconstruction Using Peroneus Longus Tendon Autograft: A Prospective Longitudinal Study

This prospective longitudinal observational cohort study will characterize recovery of donor-ankle sensorimotor function in adults who have undergone primary anterior cruciate ligament reconstruction using a peroneus longus tendon autograft. Twenty participants aged 18 to 55 years will be evaluated at postoperative 6-8 weeks, 3 months, and 6 months. The donor limb and the contralateral non-donor limb will be compared using surface electromyography of the peroneus longus, force-platform measures of postural control, inertial-sensor gait analysis, active ankle joint-position sense testing, and clinical and patient-reported foot and ankle function measures. The study does not assign the surgical procedure or rehabilitation treatment.

Study Overview

Detailed Description

Peroneus longus tendon autograft is used as an alternative graft source for anterior cruciate ligament reconstruction, but the longitudinal course of donor-site sensorimotor recovery has not been sufficiently described with objective measures. This study is designed to examine within-participant changes over time and differences between the donor and contralateral non-donor limbs.

Eligible participants who underwent primary unilateral anterior cruciate ligament reconstruction with a peroneus longus tendon autograft at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital or Halil Şıvgın Çubuk State Hospital and who are referred to the Sports Health Unit of Gazi University will be followed at postoperative 6-8 weeks, 3 months, and 6 months. No graft type, surgery, or rehabilitation intervention is assigned by the investigators.

At each assessment, peroneus longus activation will be recorded during single-leg heel-rise and medially inclined heel-rise tasks using surface electromyography and normalized to a session-specific maximal voluntary isometric contraction. Postural control will be assessed with KFORCE Plates during double-leg and single-leg balance tasks. Spatiotemporal gait and pelvic kinematics will be recorded with the G-Walk inertial sensor system. Active ankle joint-position sense will be assessed on a Cybex NORM dynamometer using a 15-degree eversion target. Foot and ankle function will be assessed using the Foot and Ankle Ability Measure.

The primary analysis will examine time, limb, and time-by-limb effects across the three postoperative assessments. Parametric data will be analyzed using two-way repeated-measures analysis of variance, with nonparametric alternatives used when assumptions are not met. The planned enrollment is 20 participants, allowing for approximately 20% attrition from the minimum required sample of 16 completers.

Study Type

Observational

Enrollment (Estimated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Ankara
      • Çankaya, Ankara, Turkey (Türkiye), 06490
        • Gazi University Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Sports Health Unit
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adults aged 18 to 55 years who have undergone primary unilateral anterior cruciate ligament reconstruction using a peroneus longus tendon autograft as part of routine clinical care and are referred to the Sports Health Unit, Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Gazi University, for postoperative rehabilitation and functional assessment. Eligible participants will be enrolled consecutively during the study period.

Description

Inclusion Criteria:

  • Age 18 to 55 years.
  • Unilateral primary anterior cruciate ligament tear confirmed by clinical examination and magnetic resonance imaging.
  • Primary anterior cruciate ligament reconstruction performed using a peroneus longus tendon autograft.
  • Able and willing to attend the postoperative assessments at 6-8 weeks, 3 months, and 6 months.
  • Written informed consent provided before study participation.

Exclusion Criteria:

  • Multiligament knee injury.
  • Previous surgery on the index knee or donor ankle.
  • Pre-existing ankle instability or major foot or ankle pathology.
  • Neurological or neuromuscular disease.
  • Inflammatory or systemic disease that may affect the assessments.
  • Major lower-extremity deformity that may affect the assessments.
  • Unable to complete the postoperative rehabilitation program or scheduled follow-up assessments.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Peroneus Longus Tendon Autograft ACLR Cohort
Adults after primary unilateral ACL reconstruction using a peroneus longus tendon autograft. Participants will undergo observational assessments at postoperative 6-8 weeks, 3 months, and 6 months. Donor-limb measures will be compared with measurements from the contralateral non-donor limb. No intervention is assigned by the study.
Participants undergo primary anterior cruciate ligament reconstruction using a peroneus longus tendon autograft as part of their routine clinical care. The graft choice and surgical procedure are determined by the treating orthopedic surgeon independently of study participation. The study does not assign or modify the graft choice, surgical technique, or postoperative rehabilitation. Participants receive routine postoperative rehabilitation according to their clinical needs, while donor-ankle sensorimotor recovery is assessed prospectively at 6-8 weeks, 3 months, and 6 months after surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Mean Center of Pressure Velocity During Single-Leg Balance
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Mean center of pressure (CoP) velocity during a 10-second single-leg stance, assessed separately with eyes open and eyes closed on KFORCE Plates. Each limb will be tested in three trials, and the mean for each condition will be used. Values are expressed in millimeters per second (mm/s); lower values indicate less postural sway. Change from the postoperative 6-8-week assessment to 3 and 6 months and donor-versus-contralateral limb differences will be evaluated.
Postoperative 6-8 weeks, 3 months, and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in CoP Path Length During Single-Leg Balance
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Total CoP path length during a 10-second single-leg stance with eyes open and eyes closed on KFORCE Plates, averaged across three valid trials for each limb and condition. Unit: millimeters (mm); lower values indicate less sway.
Postoperative 6-8 weeks, 3 months, and 6 months
Change in CoP Ellipse Area During Single-Leg Balance
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Ellipse area of CoP excursion during a 10-second single-leg stance with eyes open and eyes closed on KFORCE Plates, averaged across three valid trials. Unit: square millimeters (mm²); lower values indicate less sway area.
Postoperative 6-8 weeks, 3 months, and 6 months
Change in Mean CoP Velocity During Double-Leg Balance
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Mean CoP velocity during 30-second double-leg quiet stance with eyes open and eyes closed on KFORCE Plates, averaged across three trials per condition. Unit: millimeters per second (mm/s).
Postoperative 6-8 weeks, 3 months, and 6 months
Change in CoP Path Length During Double-Leg Balance
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Total CoP path length during 30-second double-leg quiet stance with eyes open and eyes closed on KFORCE Plates, averaged across three trials per condition. Unit: millimeters (mm).
Postoperative 6-8 weeks, 3 months, and 6 months
Change in CoP Ellipse Area During Double-Leg Balance
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Ellipse area of CoP excursion during 30-second double-leg quiet stance with eyes open and eyes closed on KFORCE Plates, averaged across three trials per condition. Unit: square millimeters (mm²).
Postoperative 6-8 weeks, 3 months, and 6 months
Change in Mean Normalized Peroneus Longus RMS Amplitude During Single-Leg Heel Rise
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Mean root-mean-square surface EMG amplitude of the peroneus longus during the concentric, isometric, and eccentric phases of a metronome-paced single-leg heel rise. Each phase is reported separately as a percentage of session-specific maximal voluntary isometric contraction (%MVIC), averaged across three repetitions for each limb.
Postoperative 6-8 weeks, 3 months, and 6 months
Change in Peak Normalized Peroneus Longus RMS Amplitude During Single-Leg Heel Rise
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Peak root-mean-square surface EMG amplitude during the concentric, isometric, and eccentric phases of a single-leg heel rise. Each phase is reported separately as %MVIC and averaged across three repetitions for each limb.
Postoperative 6-8 weeks, 3 months, and 6 months
Change in Mean Normalized Peroneus Longus RMS Amplitude During Incline Heel Rise
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Mean root-mean-square surface EMG amplitude during the concentric, isometric, and eccentric phases of a single-leg heel rise on a rigid platform with approximately 30 degrees of medial inclination. Each phase is reported separately as %MVIC and averaged across three repetitions for each limb.
Postoperative 6-8 weeks, 3 months, and 6 months
Change in Peak Normalized Peroneus Longus RMS Amplitude During Incline Heel Rise
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Peak root-mean-square surface EMG amplitude during the concentric, isometric, and eccentric phases of the medially inclined single-leg heel-rise task. Each phase is reported separately as %MVIC and averaged across three repetitions for each limb.
Postoperative 6-8 weeks, 3 months, and 6 months
Change in Ankle Joint Position Sense Absolute Error
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Absolute difference between the 15-degree eversion target and the angle reproduced by the participant during active joint-position sense testing with eyes closed on a Cybex NORM dynamometer. Each limb will be evaluated separately. Unit: degrees (°); lower values indicate greater position-sense accuracy.
Postoperative 6-8 weeks, 3 months, and 6 months
Change in Self-Selected Gait Speed
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Walking speed recorded with the G-Walk inertial sensor during self-selected walking over an approximately 10-meter walkway. The middle portion of the walk will be analyzed and three trials will be averaged. Unit: meters per second (m/s).
Postoperative 6-8 weeks, 3 months, and 6 months
Change in Gait Cadence
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Cadence recorded with the G-Walk inertial sensor during self-selected walking, averaged across three trials. Unit: steps per minute.
Postoperative 6-8 weeks, 3 months, and 6 months
Change in Step Length
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Step length recorded with the G-Walk inertial sensor during self-selected walking, averaged across three trials. Unit: meters (m).
Postoperative 6-8 weeks, 3 months, and 6 months
Change in Gait Symmetry Index
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Between-limb gait symmetry index derived from G-Walk spatiotemporal data. Unit: percent (%); values closer to the device-defined symmetry reference indicate greater symmetry.
Postoperative 6-8 weeks, 3 months, and 6 months
Change in Pelvic Tilt During Gait
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Sagittal-plane pelvic tilt measured by the G-Walk inertial sensor during self-selected walking, averaged across three trials. Unit: degrees (°).
Postoperative 6-8 weeks, 3 months, and 6 months
Change in Pelvic Obliquity During Gait
Time Frame: Postoperative 6-8 weeks, 3 months, and 6 months
Frontal-plane pelvic obliquity measured by the G-Walk inertial sensor during self-selected walking, averaged across three trials. Unit: degrees (°).
Postoperative 6-8 weeks, 3 months, and 6 months
Change in FAAM Activities of Daily Living Subscale
Time Frame: Preoperative, Postoperative 6-8 weeks, 3 months, and 6 months
Foot and Ankle Ability Measure Activities of Daily Living subscale, transformed to a 0%-100% score. Higher percentages indicate better self-reported function.
Preoperative, Postoperative 6-8 weeks, 3 months, and 6 months
Change in FAAM Sports Subscale
Time Frame: Preoperative, Postoperative 6-8 weeks, 3 months, and 6 months
Foot and Ankle Ability Measure Sports subscale, transformed to a 0%-100% score. Higher percentages indicate better self-reported sport-related function.
Preoperative, Postoperative 6-8 weeks, 3 months, and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Nihan Karatas, Prof. Dr., Gazi University
  • Principal Investigator: Dudu Ozdemir Can, MSc, Gazi University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 22, 2026

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

October 1, 2027

Study Registration Dates

First Submitted

August 10, 2026

First Submitted That Met QC Criteria

August 10, 2026

First Posted (Actual)

August 13, 2026

Study Record Updates

Last Update Posted (Actual)

August 13, 2026

Last Update Submitted That Met QC Criteria

August 10, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No individual participant data sharing plan has been specified for this study.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe